Boryung Co. Ltd. (003850) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Boryung Co. Ltd. (003850:KRX), powered by AI.

Current Price
₩9,250
P/E Ratio
12.3
Market Cap
793.5B
Sector
Healthcare
What is the Boryung Co. Ltd. stock price forecast?

Boryung Co. Ltd. is currently trading at ₩9,250. View real-time AI analysis on Alpha Lenz.

What is Boryung Co. Ltd. insider trading activity?

View the latest insider trading data for Boryung Co. Ltd. on Alpha Lenz.

What is Boryung Co. Ltd.'s P/E ratio?

Boryung Co. Ltd.'s P/E ratio is 12.3.

Boryung Co. Ltd.

KRX · 003850
₩9,250+550(+6.32%)Market closedKRX regular session 09:00–15:30 KST
Ask about Boryung Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Boryung Co. Ltd. trades at a P/E of 12.3 (undervalued) with modest ROE of 7.9%. 3Y revenue CAGR of 10.2% highlights clear growth momentum.

Ask for details

Company Overview

Boryung Co. Ltd. is a renowned pharmaceutical company based in South Korea, specializing in the development, manufacturing, and distribution of medical products. Known for its commitment to healthcare innovation, Boryung Co. Ltd. primarily focuses on producing essential pharmaceuticals, including antibiotics, cardiovascular medications, and oncology drugs. This firm plays a crucial role in enhancing public health by providing high-quality, affordable medical solutions. Operating within the dynamic and highly regulated pharmaceutical industry, Boryung Co. Ltd. collaborates with various healthcare providers to ensure its products meet global safety and efficacy standards. With a presence in both domestic and international markets, the company leverages cutting-edge research and development capabilities to address emerging health challenges and cater to a diverse patient population. Boryung Co. Ltd.'s impact extends beyond drug manufacturing, as it also engages in strategic partnerships and alliances to enhance its offerings and reach. Its market presence exemplifies the vital role pharmaceuticals play in both economic growth and social welfare, reinforcing its status as a pivotal player in advancing healthcare solutions worldwide.

CEO김정균
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees1,533

Company Statistics

FY 2025

Profile

₩793,531,664,750Market Cap
₩1,017,427,357,540Revenue
85.79MShares Out
1,533Employees

Margins

36.59%Gross
11.14%EBITDA
6.40%Operating
6.87%Pre-Tax
6.32%Net

Valuation

12.34P/E
0.94P/B
0.78EV/Sales
7.90EV/EBITDA
7.69P/FCF

Growth (CAGR)

10.19%Rev 3Yr
12.61%Rev 5Yr
4.75%Op Inc 3Yr
10.23%Op Inc 5Yr
15.31%Net Inc 3Yr
19.08%Net Inc 5Yr

Returns

5.04%ROA
7.89%ROE
6.38%ROIC

Financial Health

₩227,612,718,630Cash & Cash Equivalents
₩314,764,845,220Net Debt
64.15%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Boryung Co. Ltd. (ticker: 003850) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 1,533 employees. Market cap is $793.5B.

The current price is ₩9,250 with a P/E ratio of 12.34x and P/B of 0.94x.

ROE is 7.89% and operating margin is 6.40%. Annual revenue is $1.0T.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Boryung Co. Ltd. (003850) Stock Forecast 2026 ₩9,250 — Price, Financials & Analyst Targets | Alpha Lenz